An Ovarian Cancer Patient Presenting Heparin - Induced Thrombocytopenia after use of Low - Molecular - Weight Heparin: A Case Report of Rare Condition

Yasin Durmuş
Yalin Ay Karyal
Cigdem Kilic
Caner Cakir
Dilek Yuksel
Berna Seyhan
Gokhan Boyraz
Gunsu Kimyon Comert
Taner Turan
Full Text: PDF

Abstract

Heparin-induced thrombocytopenia is a rare and life-threatening condition of exposure to heparin. A case of heparin-induced thrombocytopenia due to the low molecular weight heparin was presented. Pulmonary emboli and progressively decreased number of thrombocytes developed during the low molecular weight heparin treatment. For that reason, the heparin-induced thrombocytopenia was diagnosed. The heparin was ceased and fondaparinux treatment initiated. Platelet levels returned to normal limits within six days. The delaying in diagnosis of heparin-induced thrombocytopenia causes serious outcomes. The physician must be careful and keep in mind be developed of this clinical condition in patient under heparin treatment.

Keywords

Heparin-induced thrombocytopenia, Low molecular weight heparin, Ovarian cancer.


DOI: http://dx.doi.org/10.21613/GORM.2018.799

Copyright (c) 2018 Gynecology Obstetrics & Reproductive Medicine

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.